Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors

Torgun Wæhre, Arne Yndestad, Camilla Smith, Terje Haug, Siv H. Tunheim, Lars Gullestad, Stig S. Frøland, Anne Grete Semb, Pål Aukrust, Jan Kristian Damås

Circulation · 2004 · 164 citations · 17 references

Abstract

Our findings suggest that cytokines in the IL-1 family may represent therapeutic targets in CAD. The ability of statins to modulate these cytokines in an anti-inflammatory direction underscores their immunomodulatory potential.

References

17